Fluor Corporation has been chosen by VaxGen Inc. to provide services for the development of two biopharmaceutical manufacturing facilities.
Lonza Group Limited (Basel, Switzerland) has selected a site for a cGMP facility that will produce microbial biopharmaceuticals.
Akzo Nobel has announced a new EUR 18 million investment for its Pharma business unit Diosynth to increase its biopharmaceutical upstream manufacturing capacity in Oss, The Netherlands.
The Immunex Corporation is to build a biopharmaceutical complex in Seattle, Wahington, worth USD 750 million.
Jacobs Engineering Group Inc. has won a contract from Koch Petroleum Group for project and construction management services of Koch's grassroots No. 3 Hydrogen Plant.